CERC-002

null · Aevi Genomic Medicine, LLC, a Cerecor company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CERC-002, covering 2022-03-04 to 2022-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury [Phase 2]